Accelerated arterial and venous clots in a young pregnant woman: a saga of thrombotic storm

Aryal, Madan Raj; Badal, Madan; Bhandari, Naresh; Bhatt, Vijaya Raj
May 2013
BMJ Case Reports;May2013, p1
Academic Journal
No abstract available.


Related Articles

  • Ultrasound and thrombolysis. Francis, C.W.; Suchkova, V.N. // Vascular Medicine;2001, Vol. 6 Issue 3, p181 

    Thrombolytic therapy and mechanical interventions are frequently used in the treat-ment of both arterial and venous thrombotic disease. Limitations to these approaches include failure to achieve reperfusion and complications including bleeding and vessel wall damage. Increasing evidence...

  • Cocaine and thrombosis: a narrative systematic review of clinical and in-vivo studies. Wright, Nat M. J.; Martin, Matthew; Goff, Tom; Morgan, John; Elworthy, Rebecca; Ghoneim, Shariffe // Substance Abuse Treatment, Prevention & Policy;2007, Vol. 2, p27 

    Purpose: To systematically review the literature pertaining to the link between cocaine and either arterial or venous thrombosis. Procedures: Narrative systematic review of Medline, CINAHL, Embase, Psycinfo and Cochrane databases supplemented by hand trawling of relevant journals and reference...

  • Postpartum Thrombotic Thrombocytopenic Purpura (TTP) Complicating Pregnancy-associated Immune Thrombocytopenic Purpura (ITP). Olenich, Martee; Schattner, Elaine // Annals of Internal Medicine;5/15/94, Vol. 120 Issue 10, p845 

    Presents a case report on a young pregnant woman with refractory immune thrombocytopenic purpura who developed postpartum thrombotic thrombocytopenic purpura. Medical record of the patient; Results and discussion.

  • Essential Thrombocythemia in Young Adults: Major Thrombotic Complications and Complications During Pregnancy -- A Follow-up Study in 68 Patients. Randi, Maria Luigia; Rossi, Carla; Fabris, Fabrizio; Girolami, Antonio // Clinical & Applied Thrombosis/Hemostasis;Jan2000, Vol. 6 Issue 1, p31 

    Objectives: Although essential thrombocythemia (ET) is usually primarily considered a disorder of middle age, it has been observed in children and young adults. However, the real risk for thrombosis in these patients has not been clearly established. Design: Prospective analysis of consecutive...

  • Primary Antiphospholipid Antibody Syndrome: A Case Report. KADELI, DEEPAK K.; HANJAGI, SIDDARAYA Y. // Journal of Clinical & Diagnostic Research;Oct2015, Vol. 9 Issue 10, p4 

    Primary Antiphospholipid antibody syndrome is a rare disease associated with thromboembolic events which may affect either the arterial or the venous vasculature. It presents with an increased risk of thrombosis in pregnant woman leading to repeated fetal losses. We present here a case of...

  • Complex Coronary Sinus Fistula in a 58-year-old Female Blackham, Ruth E.; Yamen, Eric; Hockings, Bernard E.F.; vanden Driesen, Rohan I.; Alvarez, John M. // Heart, Lung & Circulation;Aug2009, Vol. 18 Issue 4, p304 

    Coronary artery aneurysms and arterio-venous fistulae are uncommon malformations. We report the case of a 58-year-old woman with a large aneurysmal fistula arising from the left coronary tree and involving the entire coronary sinus venous system, resulting in significant left-to-right shunt. We...

  • Afectare trombotica arteriala si venoasa recurenta - care este elementul comun? Caraiola, Simona; Jurcut, C.; Tanasescu, C. // Romanian Journal of Cardiology;Dec2011, Vol. 21 Issue 4, p327 

    Previous studies reported an increased cardiovascular risk in patients with systemic lupus erythematosus, especially in the presence of the secondary antiphospholipid syndrome. We present a case-report of a woman with systemic lupus erythematosus associating secondary antiphospholipid syndrome...

  • The Involvement of Blood Coagulation Factor XIII in Fibrinolysis and Thrombosis. Muszbek, L.; Bagoly, Z.; Bereczky, Z.; Katona, É. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2008, Vol. 6 Issue 3, p190 

    It has been known for a long time that blood coagulation factor XIII (FXIII) is essential for maintaining haemostasis, its deficiency leads to severe bleeding complication. Biochemical studies have revealed that FXIII is a key regulator of fibrinolysis and, in addition to its role in...

  • Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care. Hawkins, David // American Journal of Health-System Pharmacy;11/15/2003 Supplement 7, Vol. 60, p2 

    Describes the evolution of the management and treatment of thrombotic disorders and venous thromboembolism in particular. Role of factor Xa inhibition in the continuum of care; Prevention and treatment of venous and arterial thrombotic disorders; Efficacy and safety of a selective synthetic...

  • Protein C values in coronary artery disease. O'Connor, N.T.J.; Broekmans, A.W.; Bertina, R.M. // British Medical Journal (Clinical Research Edition);11/3/1984, Vol. 289 Issue 6453, p1192 

    Examines protein C values in patients with coronary artery disease. Risk factors of the disease; Aetiology of coronary artery disease; Association of protein C deficiency with venous thrombotic disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics